Skip to content

In Vitro Diagnostic Radioimmunoassay

by Micromedic Systems 510(k)

Active United States

510(k) K813525

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK813525 Date31 Dec 1981ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
JLW
Device Class
Class II
Regulation
21 CFR Part 862.1690
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 27 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The In Vitro Diagnostic Radioimmunoassay is a laboratory test used to measure thyroid-stimulating hormone levels in blood samples. This diagnostic tool utilizes radioactive tracers to detect and quantify specific hormones with high sensitivity. It is classified as a Class II medical device under product code JLW, with special controls applied to ensure safety and effectiveness.

The device is supplied for laboratory use and is intended for in vitro diagnostic applications. It received FDA 510(k) clearance on December 31, 1981, with a decision code of SESE, indicating substantial equivalence. The device is manufactured by Micromedic Systems in McHenry, Illinois, and is regulated under FDA regulation number 862.1690.

Other devices from Micromedic Systems

See all devices from Micromedic Systems →

Questions

AI-generated answers, 27 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the In Vitro Diagnostic Radioimmunoassay used for?

    The In Vitro Diagnostic Radioimmunoassay is a laboratory test specifically designed to measure thyroid-stimulating hormone levels in blood samples. It utilizes radioactive tracers to detect and quantify specific hormones with high sensitivity, making it a valuable diagnostic tool for thyroid function assessment.

  • How is the In Vitro Diagnostic Radioimmunoassay supplied?

    The device is supplied for laboratory use and is intended for in vitro diagnostic applications only. It is manufactured by Micromedic Systems in McHenry, Illinois, and is regulated under FDA regulation number 862.1690, ensuring proper handling and application in laboratory settings.

  • What is the regulatory status of this device?

    The In Vitro Diagnostic Radioimmunoassay received FDA 510(k) clearance on December 31, 1981, with a decision code of SESE, indicating substantial equivalence. It is classified as a Class II medical device under product code JLW, with special controls applied to ensure safety and effectiveness.

  • Is this device reusable or single-use?

    The device description does not specify whether the In Vitro Diagnostic Radioimmunoassay is designed for single-use or reuse. As a laboratory test utilizing radioactive tracers, it would typically be used according to laboratory protocols and safety guidelines for handling radioactive materials.